MEDROXYPROGESTERONE ACETATE INJECTABLE S
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The Defense Logistics Agency has awarded DMS PHARMACEUTICAL GROUP INC under contract SPE2DP26F8272 for the delivery of MEDROXYPROGESTERONE ACETATE INJECTABLE S, identified by NSN 6505015295618 and PR 7017631911, with a total contract value of $120.63. The award was issued on July 24, 2026, and is linked as a delivery order under the parent contract SPE2DX25D9900. The item is procured by the Department of Defense for federal use, with no specified set-aside or NAICS code, and the place of performance and office address details are not provided in the documentation. The award notice is accessible via the DIBBS portal, reflecting standard federal procurement procedures for pharmaceutical supplies.
General Info
Agency
Contract Value
$120.63NAICS
Place of Performance
Not specifiedSet-Aside
Awardee
Award Issued Date
Documents
(2)AI Contract Breakdown
Uniform Contract FormatWhat is UCF?
Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.
Timeline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → Defense Logistics Agency
Same awarding agency
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 650+ contractors already using CLEATUS
